====== Ridgeback Biotherapeutics ======

{{ :pharmaceutical_companies:ridgeback-bio-logo.png?200|}}

**Ridgeback Biotherapeutics** is a biotechnology company based in Miami, Florida.((Moody, M., Ryan, P., Dannenbaum, P., Kruper, R., & Carvalho, C. (2021, October 1). //Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study.// Merck. Retrieved December 5, 2021, from https://archive.ph/Ov4Cg))

Ridgeback collaborated with [[Merck]] to develop [[:molnupiravir]], an oral mutagenic anti-viral compound, to treat [[:COVID-19]].((Linnane, C. (2022, January 18). //Merck and Ridgeback Biotherapeutics to supply 3 million doses of COVID antiviral to Unicef in 2022.// MarketWatch. https://archive.ph/ZbutW))